← Browse by Condition
Medical Condition
insulin sensitivity
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2, Phase 4
ClinicalMetric tracks all active clinical trials for insulin sensitivity sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — insulin sensitivity Clinical Trials
How many clinical trials are currently recruiting for insulin sensitivity?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for insulin sensitivity, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for insulin sensitivity?
insulin sensitivity research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a insulin sensitivity clinical trial?
Eligibility criteria for insulin sensitivity trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 4 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05337098
Recruiting
Non-Nutritive Sweetener Consumption and Glucose Homeostasis in Older Adults With Prediabetes
Enrollment
30 pts
Location
United States
Sponsor
Virginia Polytechnic Institute...
NCT06550115
Recruiting
Impact of Circulating and Tissue-specific Lipids on Vascular Function and Insulin Sensitivity in Chronic Night Shift Workers
Enrollment
50 pts
Location
United States
Sponsor
Colorado State University
NCT07247734 Phase 2
Recruiting
The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation
Enrollment
26 pts
Location
Denmark
Sponsor
Asger Lund, MD
NCT05764200
Recruiting
Acute Microbial Switch
Enrollment
28 pts
Location
Netherlands
Sponsor
Maastricht University Medical ...
NCT05833217
Recruiting
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
Enrollment
55 pts
Location
United States
Sponsor
Stanford University
NCT06939959 Phase 4
Recruiting
Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.
Enrollment
126 pts
Location
Pakistan
Sponsor
Khyber Teaching Hospital
NCT07265323
Recruiting
Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
Enrollment
8 pts
Location
United States
Sponsor
Pennington Biomedical Research...
NCT04966351
Recruiting
Countermeasures to Circadian Misalignment
Enrollment
32 pts
Location
United States
Sponsor
Colorado State University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology